about
Kidney stone disease.Experimental models of renal calcium stones in rodentsNADPH oxidase as a therapeutic target for oxalate induced injury in kidneysThe distinct roles of anion transporters Slc26a3 (DRA) and Slc26a6 (PAT-1) in fluid and electrolyte absorption in the murine small intestineFasting versus 24-h urine pH in the evaluation of nephrolithiasis.Apocynin-treatment reverses hyperoxaluria induced changes in NADPH oxidase system expression in rat kidneys: a transcriptional studySkeletal health of children and adolescents with inflammatory bowel disease.Primary and secondary hyperoxaluria: Understanding the enigmaACP Best Practice No 181: Chemical pathology clinical investigation and management of nephrolithiasis.Association of estimated glomerular filtration rate with 24-h urinalysis and stone composition.Oxalate-degrading microorganisms or oxalate-degrading enzymes: which is the future therapy for enzymatic dissolution of calcium-oxalate uroliths in recurrent stone disease?Approach to the Adult Kidney Stone FormerOxalate nephropathy in systemic sclerosis: Case series and review of the literature.Urogenital complications of Crohn's disease.Urolithiasis and crohn's disease.NALP3-mediated inflammation is a principal cause of progressive renal failure in oxalate nephropathy.Urolithiasis in inflammatory bowel disease and bariatric surgery.Mesalazine-induced renal calculi.Dietary management of IBD--insights and advice.The role of intestinal oxalate transport in hyperoxaluria and the formation of kidney stones in animals and man.Urolithiasis: evaluation, dietary factors, and medical management: an update of the 2014 SIU-ICUD international consultation on stone disease.Stones in special situations.Mechanisms of Stone Formation.Biochemical evaluation in renal stone disease.Evaluation of urinary oxalate levels in patients receiving gastrointestinal lipase inhibitor.[Crohn's disease and kidney stones: much more than coincidence?].
P2860
Q24536113-1C4ABBB1-407A-4C25-9153-F2974931148CQ26765054-E09B932F-473C-4AA9-A65F-5E1BD3579353Q27014373-8D59C477-32E1-4D91-8A24-F9DD7188D839Q33883184-0AB5F821-8691-4607-B813-E4954A6D8CCAQ33923986-25A31347-746E-400B-933C-07C53515ED19Q34455371-0E776D6A-46D0-4381-91B4-83D08DC04F62Q35065044-B5D5A350-9574-4087-9072-895DF3993359Q35567868-D97D3C64-ACCB-48A8-844B-2329A10E7BC8Q35588351-A6B5E25E-817D-47A5-AA3C-D510251DFC70Q35843164-10BCC13C-B7CF-45FE-BE51-2FB016E249AAQ35863258-2889D505-ECD2-4BD7-AA77-6611C30738E7Q35990584-5FC34231-2292-4E44-B2C5-A617ED14808AQ36307532-F01F17BE-A559-40BA-A23D-958760F7F46CQ36687469-F3ED40AA-72D0-4A02-B645-70A52B59AF96Q37094276-379EB18D-6347-46BB-B5A7-98B9FCDFF718Q37170509-21FC826B-AE25-41E8-8DB8-0826AF310992Q37399700-09C2E1A5-7E59-4A10-8375-C53E38A1F299Q37528584-8D875E5C-AD3A-40D7-984A-2092E1693585Q38342102-005165A3-46DF-47EC-B737-B797A9602654Q38406458-4F388C94-17A0-4156-BEBB-83B38652F8A5Q39119052-FF42359A-5C13-48E5-A96C-AFD71841DFC8Q39167381-AB1A574A-6BB8-45F3-A712-7EA10A3232BBQ40198027-EAAE12B2-E04E-4182-9685-971721BC0F5BQ41891212-3C5A1E50-99F7-4C94-AE76-A3CE1A698DD9Q46615562-9B0DAFAC-93A8-4829-B272-D2F5C5F8F98EQ46865542-554ADBF7-3BA7-4EF1-87AC-57C4E183DA63
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Stones from bowel disease.
@ast
Stones from bowel disease.
@en
type
label
Stones from bowel disease.
@ast
Stones from bowel disease.
@en
prefLabel
Stones from bowel disease.
@ast
Stones from bowel disease.
@en
P1476
Stones from bowel disease.
@en
P2093
Elaine M Worcester
P304
P356
10.1016/S0889-8529(02)00035-X
P577
2002-12-01T00:00:00Z